Autosomal Dominant Macrothrombocytopenia

Watchlist
Retrieved
2021-01-23
Source
Trials
Genes
Drugs

This syndrome is characterized by congenital thrombocytopenia associated with the presence of large platelets.

Epidemiology

To date less than 10 cases are reported.

Clinical description

Autosomal dominant macrothrombocytopenia is caused by mutations in the integrin, beta 3 ITGB3, tubulin, beta-1TUBB1 and actinin, alpha1 ACTN1 genes. These mutations lead to abnormal proplatelets and thrombocytopenia.

Etiology

Transmission is autosomal dominant.